Authors: Thomas, CE Schiedner, G Kochanek, S Castro, MG Lowenstein, PR

Citation: Ce. Thomas et al., Preexisting antiadenoviral immunity is not a barrier to efficient and stable transduction of the brain, mediated by novel high-capacity adenovirus vectors, HUM GENE TH, 12(7), 2001, pp. 839-846

Authors: Biermann, V Volpers, C Hussmann, S Stock, A Kewes, H Schiedner, G Herrmann, A Kochanek, S

Citation: V. Biermann et al., Targeting of high-capacity adenoviral vectors, HUM GENE TH, 12(14), 2001, pp. 1757-1769

Authors: Schiedner, G Hertel, S Kochanek, S

Citation: G. Schiedner et al., Efficient transformation of primary human amniocytes by E1 functions of Ad5: Generation of new cell lines for adenoviral vector production, HUM GENE TH, 11(15), 2000, pp. 2105-2116

Authors: Thomas, CE Schiedner, G Kochanek, S Castro, MG Lowenstein, PR

Citation: Ce. Thomas et al., Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but notwith high-capacity, adenovirus vectors: Toward realistic long-term neurological gene therapy for chronic diseases, P NAS US, 97(13), 2000, pp. 7482-7487

Authors: Burcin, MM Schiedner, G Kochanek, S Tsai, SY O'Malley, BW

Citation: Mm. Burcin et al., Adenovirus-mediated regulable target gene expression in vivo, P NAS US, 96(2), 1999, pp. 355-360

Authors: Morral, N Parks, RJ Zhou, HS Langston, C Schiedner, G Quinones, J Graham, FL Kochanek, S Beaudet, AL

Citation: N. Morral et al., High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alpha(1)-antitrypsin with negligible toxicity, HUM GENE TH, 9(18), 1998, pp. 2709-2716